Motif ID: Nr1i3
Z-value: 1.486
Transcription factors associated with Nr1i3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Nr1i3 | ENSMUSG00000005677.8 | Nr1i3 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Nr1i3 | mm10_v2_chr1_+_171213969_171214007 | -0.08 | 5.6e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.3 | 24.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 4.3 | 12.8 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 3.2 | 9.5 | GO:0021557 | oculomotor nerve development(GO:0021557) |
| 3.0 | 3.0 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 2.8 | 13.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 2.6 | 7.9 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 2.5 | 7.4 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
| 2.4 | 9.7 | GO:0015889 | cobalamin transport(GO:0015889) |
| 2.4 | 7.2 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 2.0 | 6.0 | GO:0060166 | olfactory pit development(GO:0060166) |
| 2.0 | 2.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 2.0 | 2.0 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 1.8 | 33.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 1.8 | 12.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.7 | 5.2 | GO:0036292 | DNA rewinding(GO:0036292) |
| 1.7 | 3.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
| 1.7 | 5.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 1.7 | 6.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 1.7 | 5.0 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.7 | 6.6 | GO:0030091 | protein repair(GO:0030091) |
| 1.7 | 5.0 | GO:1905066 | regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 1.6 | 4.7 | GO:0046544 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) |
| 1.6 | 4.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 1.5 | 4.5 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 1.5 | 4.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 1.5 | 13.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 1.4 | 1.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 1.4 | 5.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.4 | 4.3 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 1.4 | 6.8 | GO:0021764 | amygdala development(GO:0021764) |
| 1.4 | 14.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 1.3 | 5.3 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
| 1.3 | 7.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 1.3 | 3.9 | GO:0010752 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cGMP-mediated signaling(GO:0010752) |
| 1.3 | 5.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.3 | 10.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 1.3 | 7.5 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 1.2 | 7.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 1.1 | 3.4 | GO:0038044 | negative regulation of receptor biosynthetic process(GO:0010871) transforming growth factor-beta secretion(GO:0038044) |
| 1.1 | 4.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
| 1.1 | 2.2 | GO:0036166 | phenotypic switching(GO:0036166) |
| 1.1 | 1.1 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 1.1 | 10.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 1.0 | 5.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 1.0 | 5.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
| 1.0 | 6.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 1.0 | 7.2 | GO:0000279 | M phase(GO:0000279) |
| 1.0 | 3.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 1.0 | 5.1 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 1.0 | 3.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 1.0 | 9.0 | GO:0048664 | neuron fate determination(GO:0048664) |
| 1.0 | 7.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 1.0 | 4.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 1.0 | 17.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 1.0 | 2.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 1.0 | 2.9 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.0 | 2.9 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 1.0 | 3.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 1.0 | 3.8 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.0 | 2.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.0 | 5.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.9 | 8.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.9 | 6.4 | GO:2001225 | regulation of chloride transport(GO:2001225) |
| 0.9 | 8.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.9 | 5.4 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.9 | 4.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.9 | 3.6 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 0.9 | 1.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.9 | 4.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.9 | 7.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.9 | 7.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.8 | 3.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.8 | 0.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.8 | 4.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.8 | 6.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.8 | 4.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.8 | 4.0 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.8 | 0.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.8 | 5.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.8 | 2.4 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.8 | 3.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.8 | 5.3 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.7 | 7.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.7 | 3.0 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.7 | 2.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.7 | 2.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.7 | 4.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.7 | 3.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.7 | 2.8 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.7 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 0.7 | 4.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.7 | 7.7 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.7 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.7 | 1.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.7 | 2.8 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.7 | 3.4 | GO:0098706 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.7 | 2.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.7 | 14.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.7 | 9.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.7 | 3.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.7 | 2.0 | GO:0050787 | glycolate metabolic process(GO:0009441) enzyme active site formation via L-cysteine sulfinic acid(GO:0018323) primary alcohol biosynthetic process(GO:0034309) cellular response to glyoxal(GO:0036471) glycolate biosynthetic process(GO:0046295) detoxification of mercury ion(GO:0050787) negative regulation of TRAIL-activated apoptotic signaling pathway(GO:1903122) regulation of pyrroline-5-carboxylate reductase activity(GO:1903167) positive regulation of pyrroline-5-carboxylate reductase activity(GO:1903168) regulation of tyrosine 3-monooxygenase activity(GO:1903176) positive regulation of tyrosine 3-monooxygenase activity(GO:1903178) L-dopa metabolic process(GO:1903184) L-dopa biosynthetic process(GO:1903185) glyoxal metabolic process(GO:1903189) regulation of L-dopa biosynthetic process(GO:1903195) positive regulation of L-dopa biosynthetic process(GO:1903197) regulation of L-dopa decarboxylase activity(GO:1903198) positive regulation of L-dopa decarboxylase activity(GO:1903200) regulation of cellular amino acid biosynthetic process(GO:2000282) positive regulation of cellular amino acid biosynthetic process(GO:2000284) |
| 0.7 | 2.0 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.7 | 1.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.7 | 0.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.6 | 16.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.6 | 12.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.6 | 3.1 | GO:0018158 | protein oxidation(GO:0018158) |
| 0.6 | 6.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.6 | 7.9 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.6 | 3.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.6 | 4.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
| 0.6 | 7.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.6 | 3.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.6 | 3.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.6 | 2.3 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
| 0.6 | 1.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.6 | 8.1 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.6 | 5.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.6 | 5.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.6 | 0.6 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.6 | 1.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.6 | 2.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.6 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) mitochondrial DNA metabolic process(GO:0032042) |
| 0.6 | 1.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 2.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.6 | 3.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.5 | 2.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 | 2.2 | GO:0032439 | endosome localization(GO:0032439) |
| 0.5 | 1.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.5 | 2.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.5 | 7.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.5 | 6.7 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.5 | 4.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.5 | 1.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.5 | 1.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.5 | 2.6 | GO:0003161 | cardiac conduction system development(GO:0003161) |
| 0.5 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.5 | 2.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.5 | 5.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.5 | 1.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.5 | 1.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.5 | 2.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.5 | 1.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.5 | 4.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.5 | 6.8 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.5 | 3.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.5 | 4.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.5 | 3.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
| 0.5 | 0.9 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.5 | 3.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.5 | 1.4 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.5 | 2.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.5 | 4.7 | GO:0030432 | peristalsis(GO:0030432) |
| 0.5 | 2.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.5 | 0.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.5 | 2.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.5 | 1.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 | 1.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.4 | 1.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.4 | 1.8 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.4 | 5.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.4 | 1.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.4 | 3.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.4 | 1.7 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 2.2 | GO:0015817 | glutamine transport(GO:0006868) histidine transport(GO:0015817) cellular response to potassium ion starvation(GO:0051365) |
| 0.4 | 2.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.4 | 1.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.4 | 0.9 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.4 | 1.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.4 | 3.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.4 | 2.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.4 | 3.3 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.4 | 6.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.4 | 0.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 13.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.4 | 1.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.4 | 2.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
| 0.4 | 2.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.4 | 3.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.4 | 1.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 1.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.4 | 3.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.4 | 3.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.4 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.4 | 8.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.4 | 1.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.4 | 1.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.4 | 2.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.4 | 1.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.4 | 1.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
| 0.4 | 3.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.4 | 1.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.4 | 3.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.4 | 2.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 | 2.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.4 | 1.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.4 | 14.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.4 | 1.1 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.4 | 12.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.3 | 2.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.3 | 3.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 | 1.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.3 | 1.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.3 | 2.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 | 2.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.3 | 2.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.3 | 1.7 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
| 0.3 | 2.0 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.3 | 20.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.3 | 0.3 | GO:0050713 | negative regulation of interleukin-1 secretion(GO:0050711) negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.3 | 1.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.3 | 1.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.3 | 2.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.3 | 1.3 | GO:0015744 | succinate transport(GO:0015744) |
| 0.3 | 1.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.3 | 0.3 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.3 | 0.7 | GO:0042637 | catagen(GO:0042637) |
| 0.3 | 1.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.3 | 2.0 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.3 | 1.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 4.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.3 | 2.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 | 3.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.3 | 1.0 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.3 | 1.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.3 | 1.6 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.3 | 1.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 | 1.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.3 | 1.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.3 | 2.2 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.3 | 1.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.3 | 8.5 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.3 | 2.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 | 9.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.3 | 0.6 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.3 | 0.9 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.3 | 2.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.3 | 1.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.3 | 1.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.3 | 0.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 0.9 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 | 1.5 | GO:0060430 | lung saccule development(GO:0060430) |
| 0.3 | 1.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.3 | 0.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.3 | 2.6 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
| 0.3 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 1.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.3 | 1.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 | 0.9 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
| 0.3 | 0.3 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
| 0.3 | 2.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.3 | 3.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.3 | 1.4 | GO:0061084 | negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.3 | 1.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 | 2.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 | 1.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.3 | 1.9 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
| 0.3 | 3.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.3 | 3.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.3 | 0.8 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.3 | 2.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.3 | 3.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 | 2.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
| 0.3 | 0.8 | GO:2000278 | regulation of DNA biosynthetic process(GO:2000278) |
| 0.3 | 7.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.3 | 1.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 1.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.3 | 1.0 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.3 | 3.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.3 | 2.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 | 0.8 | GO:0030202 | heparin metabolic process(GO:0030202) |
| 0.3 | 3.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.3 | 0.8 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 | 1.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.3 | 9.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 | 0.8 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.2 | 1.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 2.2 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 | 1.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 | 1.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 0.2 | 7.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 0.7 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.2 | 0.7 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.2 | 3.4 | GO:0043486 | histone exchange(GO:0043486) |
| 0.2 | 1.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 | 1.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 0.2 | 0.7 | GO:0071500 | aggrephagy(GO:0035973) cellular response to nitrosative stress(GO:0071500) |
| 0.2 | 0.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 0.9 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.2 | 0.5 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.2 | 0.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 0.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 1.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.2 | 1.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.2 | 0.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.2 | 6.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 0.7 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.2 | 0.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 | 7.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.2 | 0.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.2 | 5.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.2 | 1.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 0.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.2 | 3.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 | 0.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 1.5 | GO:0006273 | lagging strand elongation(GO:0006273) |
| 0.2 | 1.5 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.2 | 2.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.2 | 0.7 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.2 | 0.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 0.9 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 | 2.7 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.2 | 1.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 5.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 1.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.2 | 0.6 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
| 0.2 | 2.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 | 0.4 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
| 0.2 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 | 2.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.2 | 3.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.2 | 2.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.2 | 1.9 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.2 | 1.0 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.2 | 1.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.2 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.2 | 2.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.2 | 0.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 | 2.1 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.2 | 1.1 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.2 | 0.6 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.2 | 0.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.2 | 0.9 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 3.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 | 1.5 | GO:0015074 | DNA integration(GO:0015074) |
| 0.2 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.2 | 0.7 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.2 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.2 | 0.5 | GO:0050904 | diapedesis(GO:0050904) |
| 0.2 | 0.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.2 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 1.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.2 | 2.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 0.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 0.3 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.2 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.2 | 0.5 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.2 | 0.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 | 0.3 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.2 | 2.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.2 | 0.7 | GO:0015786 | UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.2 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 4.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 | 3.7 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.2 | 0.3 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 1.5 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.2 | 1.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 0.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 1.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.2 | 1.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.2 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 2.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.2 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
| 0.2 | 0.8 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.2 | 0.6 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 | 3.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.2 | 1.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 1.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 0.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 1.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 3.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.2 | GO:0072189 | ureter development(GO:0072189) |
| 0.2 | 1.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 2.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.1 | 0.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 0.6 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
| 0.1 | 0.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 | 1.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 1.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 6.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.1 | 0.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 1.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 1.2 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 0.4 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
| 0.1 | 0.6 | GO:0060405 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
| 0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 1.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.1 | 1.4 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.1 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.1 | 0.7 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.7 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.1 | 1.5 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 2.9 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.1 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.7 | GO:0031053 | primary miRNA processing(GO:0031053) regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 | 1.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.1 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 1.7 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.1 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
| 0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 1.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 | 0.3 | GO:0002423 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
| 0.1 | 0.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.1 | 4.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.3 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.1 | 2.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 0.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.1 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 1.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 1.5 | GO:0021983 | pituitary gland development(GO:0021983) |
| 0.1 | 0.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
| 0.1 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.1 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 1.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.1 | 1.0 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
| 0.1 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 1.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.1 | 2.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 1.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.1 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 0.9 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 3.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.1 | 2.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 0.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.1 | 0.5 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.1 | 1.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.1 | 0.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 1.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 1.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 0.6 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.9 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 | 0.5 | GO:1990839 | response to endothelin(GO:1990839) |
| 0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 0.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 1.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.2 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 0.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.1 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 | 1.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.1 | 3.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 0.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 0.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.1 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 1.8 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.1 | 1.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.8 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 0.3 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 3.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 1.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 1.1 | GO:0019395 | fatty acid oxidation(GO:0019395) |
| 0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 1.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 3.6 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 | 0.4 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 | 0.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 0.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.1 | 1.4 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.1 | 2.0 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.1 | 0.6 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 0.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 | 2.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.1 | 0.3 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.1 | 0.9 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.1 | 0.8 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.1 | 0.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.1 | 2.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.8 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.6 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.9 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 | 0.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 2.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 2.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.7 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
| 0.1 | 2.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.1 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 0.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.1 | 6.3 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 1.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 3.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
| 0.1 | 0.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.2 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 1.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 0.2 | GO:0045852 | lysosomal lumen pH elevation(GO:0035752) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 | 0.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 0.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.1 | 0.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 | 1.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 1.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.1 | 0.4 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 | 1.0 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 | 0.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.1 | 1.3 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.1 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.2 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.0 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 1.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.0 | 0.4 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
| 0.0 | 2.5 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.0 | 8.5 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 | 0.4 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 | 1.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 | 0.1 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 | 1.6 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.0 | 0.4 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 | 1.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.0 | 1.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) negative regulation of cytokinesis(GO:0032466) |
| 0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 | 0.4 | GO:0016125 | sterol metabolic process(GO:0016125) |
| 0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 1.5 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
| 0.0 | 0.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 1.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 1.1 | GO:0001885 | endothelial cell development(GO:0001885) |
| 0.0 | 0.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.0 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 2.0 | GO:0006413 | translational initiation(GO:0006413) |
| 0.0 | 0.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.0 | 1.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 0.9 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
| 0.0 | 0.2 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.0 | 0.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.5 | GO:0007584 | response to nutrient(GO:0007584) |
| 0.0 | 0.3 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.0 | 0.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 | 0.8 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
| 0.0 | 0.6 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
| 0.0 | 0.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.0 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.0 | 0.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
| 0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
| 0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.0 | 0.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 24.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 2.5 | 10.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 2.4 | 7.2 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 2.2 | 6.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 2.0 | 10.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 2.0 | 6.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.9 | 3.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.6 | 8.2 | GO:0033010 | paranodal junction(GO:0033010) |
| 1.5 | 6.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 1.5 | 4.6 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.3 | 4.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 1.3 | 5.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.2 | 4.7 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 1.1 | 8.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 1.1 | 3.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 1.1 | 4.4 | GO:0032021 | NELF complex(GO:0032021) |
| 0.9 | 3.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.9 | 6.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.9 | 5.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.8 | 4.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.8 | 13.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.8 | 5.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.7 | 12.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.7 | 4.3 | GO:0043256 | laminin complex(GO:0043256) |
| 0.7 | 7.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.7 | 2.1 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
| 0.7 | 4.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.7 | 4.0 | GO:0045179 | apical cortex(GO:0045179) |
| 0.7 | 2.0 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
| 0.7 | 2.0 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.6 | 2.5 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 0.6 | 2.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.6 | 4.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.6 | 21.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.6 | 39.8 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.6 | 1.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.6 | 1.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.6 | 6.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.5 | 2.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.5 | 4.3 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.5 | 3.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.5 | 4.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.5 | 28.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.5 | 4.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.5 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.5 | 3.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.5 | 3.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.5 | 6.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.5 | 1.5 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
| 0.5 | 1.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.5 | 6.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.5 | 2.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.5 | 3.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.4 | 1.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.4 | 4.3 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 3.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.4 | 2.0 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 0.4 | 7.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.4 | 2.8 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.4 | 4.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.4 | 3.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.4 | 2.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.4 | 0.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.4 | 2.6 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.4 | 20.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.4 | 1.1 | GO:0000801 | central element(GO:0000801) |
| 0.4 | 26.1 | GO:0005657 | replication fork(GO:0005657) |
| 0.4 | 8.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 6.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.3 | 2.7 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.3 | 1.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.3 | 1.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.3 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 2.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.3 | 2.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 1.6 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
| 0.3 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 0.6 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.3 | 1.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.3 | 2.0 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.3 | 2.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.3 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 5.3 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.3 | 2.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.3 | 0.8 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.3 | 2.8 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.3 | 1.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.3 | 25.8 | GO:0000922 | spindle pole(GO:0000922) |
| 0.3 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.3 | 1.0 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.3 | 1.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.3 | 2.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 4.0 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 1.2 | GO:1990357 | terminal web(GO:1990357) |
| 0.2 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 2.2 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 17.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.2 | 1.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 2.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.2 | 0.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.2 | 2.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.2 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 3.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.2 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 6.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 1.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 2.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.2 | 10.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.2 | 0.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 2.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 0.6 | GO:1990047 | spindle matrix(GO:1990047) |
| 0.2 | 10.1 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.2 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 4.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 1.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 4.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 2.4 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 4.6 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 1.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.2 | 1.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.2 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 1.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 16.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.2 | 12.4 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.2 | 3.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.2 | 5.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.2 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.2 | 1.4 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.2 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 1.5 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 0.6 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 2.1 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 4.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.1 | 0.7 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 1.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 1.6 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 52.4 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.1 | 0.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 0.5 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) photoreceptor cell terminal bouton(GO:1990796) |
| 0.1 | 2.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 19.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 2.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 0.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.1 | 1.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 1.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 1.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.1 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 1.4 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.1 | 3.9 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 14.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 6.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 1.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 3.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 3.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 1.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 1.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 1.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 25.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 9.7 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.1 | 1.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.1 | 1.8 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 8.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 2.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 26.1 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 4.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 5.6 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 2.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.1 | 3.9 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 1.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 0.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.1 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 1.0 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.3 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.0 | 2.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.0 | 2.3 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 1.7 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.6 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 1.4 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 0.4 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 2.0 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.1 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.5 | GO:0055029 | nuclear DNA-directed RNA polymerase complex(GO:0055029) |
| 0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 4.0 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 0.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 0.1 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.3 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 4.3 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.6 | GO:0098687 | chromosomal region(GO:0098687) |
| 0.0 | 0.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.5 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.3 | GO:0005770 | late endosome(GO:0005770) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.6 | 13.8 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 4.2 | 12.6 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 4.0 | 12.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 3.3 | 13.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 3.2 | 12.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 2.9 | 17.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 2.7 | 10.8 | GO:0042806 | fucose binding(GO:0042806) |
| 2.2 | 8.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 2.0 | 6.1 | GO:0030172 | troponin C binding(GO:0030172) |
| 2.0 | 6.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 1.9 | 5.7 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 1.7 | 5.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.7 | 6.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 1.6 | 27.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 1.6 | 4.7 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 1.5 | 6.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 1.5 | 10.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 1.4 | 2.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.4 | 15.1 | GO:0008430 | selenium binding(GO:0008430) |
| 1.4 | 6.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.4 | 14.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 1.4 | 8.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 1.3 | 4.0 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 1.3 | 5.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.2 | 3.6 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 1.2 | 3.6 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 1.1 | 10.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 1.1 | 3.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 1.1 | 6.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.0 | 7.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 1.0 | 6.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 1.0 | 4.0 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 0.9 | 4.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.9 | 3.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.9 | 10.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.9 | 7.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.9 | 3.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.9 | 3.6 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.9 | 7.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.9 | 13.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.9 | 4.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.9 | 5.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.8 | 3.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.8 | 4.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.8 | 3.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.8 | 17.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.8 | 2.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.7 | 10.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.7 | 2.9 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.7 | 2.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.7 | 2.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.7 | 8.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.7 | 2.2 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.7 | 2.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.7 | 2.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.7 | 2.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
| 0.7 | 5.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.7 | 2.8 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.7 | 4.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.7 | 8.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.7 | 6.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.7 | 2.0 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
| 0.7 | 6.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.6 | 2.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.6 | 4.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.6 | 5.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.6 | 3.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.6 | 2.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.6 | 1.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.6 | 0.6 | GO:0004935 | adrenergic receptor activity(GO:0004935) alpha-adrenergic receptor activity(GO:0004936) |
| 0.6 | 4.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.6 | 4.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.6 | 5.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.6 | 4.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.6 | 2.3 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.6 | 17.9 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.6 | 1.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) |
| 0.6 | 2.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.5 | 3.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.5 | 15.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.5 | 4.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.5 | 1.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.5 | 1.5 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.5 | 5.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.5 | 3.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.5 | 1.5 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.5 | 1.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.5 | 9.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.5 | 12.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.5 | 4.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.5 | 3.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.4 | 1.3 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.4 | 14.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.4 | 1.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.4 | 4.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.4 | 19.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.4 | 7.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.4 | 4.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.4 | 5.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.4 | 2.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.4 | 1.7 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
| 0.4 | 1.2 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.4 | 4.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 4.1 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.4 | 9.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.4 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.4 | 1.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.4 | 1.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.4 | 3.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.4 | 1.2 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.4 | 0.8 | GO:0070279 | vitamin B6 binding(GO:0070279) |
| 0.4 | 4.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.4 | 7.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.4 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.4 | 1.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.4 | 1.5 | GO:0015248 | sterol transporter activity(GO:0015248) cholesterol transporter activity(GO:0017127) |
| 0.4 | 1.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 1.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 2.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.4 | 1.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.4 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.3 | 1.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.3 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.3 | 6.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.3 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.3 | 2.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 1.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.3 | 3.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.3 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.3 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 2.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 1.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.3 | 1.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.3 | 2.9 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.3 | 6.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.3 | 0.9 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
| 0.3 | 2.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 1.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.3 | 1.5 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.3 | 1.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.3 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.3 | 0.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.3 | 3.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.3 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.3 | 3.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.3 | 4.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.3 | 1.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
| 0.3 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 4.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 2.7 | GO:0048406 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
| 0.3 | 3.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.3 | 1.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.3 | 0.8 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.3 | 1.1 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.3 | 1.1 | GO:0097617 | annealing activity(GO:0097617) |
| 0.3 | 3.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.3 | 0.8 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.3 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 4.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.3 | 1.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.2 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 0.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.2 | 3.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 2.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 0.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
| 0.2 | 0.7 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.2 | 0.7 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
| 0.2 | 3.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 3.5 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.2 | 1.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 1.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.2 | 3.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.2 | 1.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 0.6 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.2 | 3.7 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.2 | 1.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 3.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 3.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.2 | 3.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 2.2 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.2 | 0.8 | GO:0070404 | NADH binding(GO:0070404) |
| 0.2 | 0.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.2 | 3.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 4.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.2 | 7.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
| 0.2 | 0.6 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 0.6 | GO:0032564 | dATP binding(GO:0032564) |
| 0.2 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.2 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 6.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.2 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 0.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.2 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.2 | 0.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.2 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.2 | 1.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.2 | 0.5 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.2 | 0.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.2 | 29.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 6.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 0.6 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.2 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.2 | 1.8 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.2 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 0.6 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.2 | 3.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 0.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.2 | 1.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
| 0.2 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 3.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.2 | 0.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.2 | 3.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 1.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
| 0.1 | 4.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.1 | 1.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 0.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.1 | 4.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 1.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 13.5 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 3.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 1.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.1 | 5.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 0.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 1.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 4.6 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 1.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 11.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 4.1 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 2.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 3.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 1.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.1 | 0.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.1 | 4.9 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
| 0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 4.1 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 5.6 | GO:0020037 | heme binding(GO:0020037) |
| 0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 1.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 2.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 1.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 3.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 1.1 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 1.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 1.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 6.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
| 0.1 | 0.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 4.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 1.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.7 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.1 | 0.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.1 | 0.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 2.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 4.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 2.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 5.5 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 0.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 5.2 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 12.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 3.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 3.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 1.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 1.2 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 2.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.9 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.4 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 24.3 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
| 0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.1 | 5.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.7 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
| 0.1 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.1 | 3.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.0 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 2.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.0 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 3.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.0 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 1.4 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.3 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
| 0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 0.2 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.0 | 1.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 4.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.6 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.0 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.0 | 0.5 | GO:0042562 | hormone binding(GO:0042562) |
| 0.0 | 0.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.0 | 3.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.0 | 1.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
| 0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.0 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.0 | 0.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.3 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.0 | 0.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.0 | 0.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.0 | 0.2 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 14.9 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.7 | 9.4 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.6 | 33.6 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.5 | 4.3 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 22.2 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.4 | 21.8 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.4 | 3.5 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 6.0 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
| 0.4 | 10.7 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.4 | 11.8 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.4 | 12.0 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.4 | 33.5 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.3 | 1.6 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 2.2 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 7.2 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.3 | 9.0 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.3 | 1.3 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.2 | 12.4 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.2 | 7.0 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 3.7 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.2 | 9.8 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 5.7 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.2 | 1.1 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.2 | 21.0 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 5.9 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 2.3 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 1.4 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 2.7 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.2 | 6.6 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 7.8 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 1.2 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.2 | 2.5 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 0.8 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.2 | 4.4 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 5.1 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.2 | 2.4 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.2 | 3.8 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.1 | 4.9 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.4 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.1 | 3.9 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 2.6 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 17.1 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 4.3 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 6.2 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.3 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.5 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 2.7 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.1 | 3.7 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.1 | 12.1 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 2.9 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.1 | 2.9 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 2.0 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 1.3 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 1.0 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 1.3 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
| 0.1 | 1.3 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
| 0.1 | 0.6 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 2.4 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.8 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 0.5 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.1 | 0.8 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.4 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.4 | PID_EPO_PATHWAY | EPO signaling pathway |
| 0.0 | 1.0 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.5 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.3 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 5.6 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.6 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.2 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 1.9 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.2 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.6 | PID_ARF6_PATHWAY | Arf6 signaling events |
| 0.0 | 0.1 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.0 | 0.3 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.8 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.0 | 0.3 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 5.3 | REACTOME_PHOSPHORYLATION_OF_THE_APC_C | Genes involved in Phosphorylation of the APC/C |
| 1.5 | 14.8 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 1.2 | 19.6 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.8 | 20.5 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.8 | 3.2 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.8 | 33.1 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.8 | 6.8 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.7 | 51.3 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
| 0.7 | 9.1 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.7 | 11.5 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.6 | 5.0 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.6 | 5.5 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.6 | 4.9 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.6 | 2.3 | REACTOME_HEMOSTASIS | Genes involved in Hemostasis |
| 0.6 | 8.0 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.6 | 3.4 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.5 | 7.2 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.5 | 16.3 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.5 | 1.4 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.4 | 11.6 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.4 | 3.8 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.4 | 6.7 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.4 | 3.6 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.4 | 37.5 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.4 | 7.0 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.4 | 6.9 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.4 | 3.6 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.4 | 2.5 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.4 | 11.3 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.4 | 14.7 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 9.0 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 4.6 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 5.5 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.3 | 3.9 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.3 | 1.3 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.3 | 5.0 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 3.0 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.3 | 5.5 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.3 | 4.6 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 3.7 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 2.6 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 1.3 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.3 | 3.5 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.2 | 0.7 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 15.7 | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.2 | 4.3 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 2.2 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 3.3 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.2 | 7.2 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 13.5 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 12.6 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.2 | 1.2 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.2 | 12.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 2.2 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.2 | 3.2 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.2 | 2.0 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 0.2 | 4.3 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.2 | 4.3 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 7.9 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 1.4 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 1.0 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 3.4 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 0.8 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.2 | 15.0 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.2 | 2.1 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
| 0.2 | 5.1 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 0.2 | 1.4 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 0.6 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 2.5 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 2.0 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 3.0 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.7 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.1 | 8.1 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 1.4 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.1 | 1.7 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 1.9 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 5.8 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 0.8 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 10.8 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 1.0 | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.1 | 1.5 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 1.1 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 0.4 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 3.7 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 0.5 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 1.1 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 0.6 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 1.2 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.7 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 0.5 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 0.3 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 1.7 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 1.6 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 1.8 | REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.1 | 0.9 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 1.9 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 1.7 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.1 | 1.9 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 0.7 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 6.1 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 0.5 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 3.7 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.4 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.8 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
| 0.1 | 0.5 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 0.5 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 3.7 | REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 0.7 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.0 | 1.0 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.5 | REACTOME_REGULATION_OF_APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.0 | 0.6 | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.0 | 0.2 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 0.5 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.0 | 0.3 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 1.7 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.7 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.6 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 1.6 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.6 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.2 | REACTOME_INTERFERON_SIGNALING | Genes involved in Interferon Signaling |
| 0.0 | 0.6 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.3 | REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 1.0 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.4 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.1 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.1 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
